LYRA vs TSN · rev $1.5M vs P/E 22, rev $54.44B
Lyra Therapeutics Inc (LYRA) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Tyson Foods Inc (TSN) is a farm products company listed on US.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
LYRA currently screens at market cap $14.4M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the LYRA and TSN stock pages for the full models.
Not investment advice.